November 24 | 2022
Interim Report Q3 2022 released
View report
October 26 | 2022
2cureX presents at Redeye Medtech event in Stockholm, Sweden
Read more
October 13 | 2022
2cureX presents at Redeye Investor AW in Malmø, Sweden
Read more
September 6 | 2022
2cureX presents at LSX Nordic Congress on Biotech, Healthtech & Medtech, Copenhagen, Denmark
Read more
August 25 | 2022
Interim Report Q2 2022 released
View report
July 2 | 2022
Exciting feedback from ESMO World Congress on Gastrointestinal Cancer 2022 in Barcelona. Interview with CEO Fernando Andreu and Medical Director Dr. Rafael Gruber.
View interview
June 29 | 2022
2cureX participates at ESMO in Barcelona, Spain; Booth 210
Read more
June 11 | 2022
2cureX participates at GI-Oncology in Wiesbaden, Germany
Read more
May 24 | 2022
Interim Report Q1 2022 released
View report
May 24 | 2022
Invitation to join the 2cureX Q1 Report webcast and Q&A session at 15:00
Link to webcast
May 11 | 2022
CSO Ole Thastrup, presents at the Society for Functional Precision Medicine, USA
Read more
May 11 | 2022
CEO Fernando Andreu, presents at Redeye Theme: Medtech & Diagnostics, Stockholm, Sweden
Read more
March 31 | 2022
2cureX presents at RedEye “Investor AW” (Malmø, Sweden)
Watch webcast
March 1 | 2022
Webinar (HC Andersen Capital): Discussion of the Year-End (Q4) 2021 Report
Registration
